New Search

If you are not happy with the results below please do another search

Generic filters

50 search results for:


Prosoma Digital Therapeutics and EVERSANA announce Commercialization partnership for new therapeutic supporting mental health and behavioral needs of cancer patients

On the heels of the upcoming major digital therapeutics show in Boston (DTx East), EVERSANA has announced a partnership with Warsaw, Poland-based Prosoma Digital Therapeutics. Together, they will work together to bring the company’s Living Well digital therapy to the U.S. to improve the quality of life and reduce stress, anxiety, and depression symptoms for patients related to a cancer diagnosis.


Biopharma makes progress against a childhood killer: Pediatric glioma

September is Childhood Cancer Awareness Month, which sheds light on the need for new developments in pediatric oncology. For American children, the number one cause of death by disease is cancer. Pediatric gliomas, the most common type of brain tumor in children, are a critical area of focus for oncology research.


Valneva in talks with potential partner on second-gen COVID-19 vaccines

The French drugmaker is in talks with a potential partner on producing an updated version of its COVID-19 vaccine that targets new variants of the disease, sending its shares up. Valneva has struggled to bring its COVID-19 vaccine to market to compete with rival products from drugmakers such as AstraZeneca, Moderna and BioNTech/Pfizer.